Results 151 to 160 of about 1,494,514 (261)

Capability of chatbots powered by large language models to support the screening process of scoping reviews: a feasibility study. [PDF]

JAMIA Open
Nordmann K, Schaller M, Sauter S, Fischer F.   +3 more
europepmc   +1 more source

ABSTRACTS

Wildlife Biology, 1991
J. G. Morgan, H. A. Pereira, T. Sukiennicki, J. K. Spitznagel, J. W. Larrick, D. R. Forsdyke, S. Blum, D. P. Sideris, R. E. Forsdyke, H. Yu, E. Carstens, T. Hattori, Y. Yamamura, Y. Ohmoto, T. Nishida, K. Takatsuki, P. Tekamp-Olson, C. Gallegos, D. Bauer, J. McClain, B. Sherry, M. Fabre, S. van Deventer, A. Cerami, M. Napolitano, W. S. Modi, V. H. Seuanez, S. J. Cevario, W. J. Leonard, T. Schall, K. Toy, D. V. Goeddel, C. A. Hébert, F. W. Luscinskas, J-M. Kiely, E. A. Luis, W. C. Darbonne, G. T. Bennett, C. C. Liu, M. S. Obin, M. A. Gimbrone, J. B. Baker, K. A. Brown, F. Le Roy, G. Noble, K. Bacon, R. Camp, A. Vora, D. C. Dumonde, P. D. Collins, P. J. Jose, T. J. Williams, M. Rampart, J. Van Damme, W. Fiers, A. G. Herman, O. Pos, M. F. Geertsma, A. Stevenhagen, P. N. Nibbering, R. van Furth, K. B. Bacon, R. D. R. Camp, A. B. Millar, A. Meager, S. J. G. Semple, G. A. W. Rook, M. Stein, S. Gordon, K. Morrison, D. B. Jones, E. Y. Jones, D. I. Stuart, N. P. C. Walker, M. K. Thomsen, C. G. Larsen, K. Thestrup-Pedersen, M. Kristensen, K. Paludan, B. Deleuren, K. Kragballe, K. Matsushima, J. M. Wang, G. Taraboletti, A. Mantovani, A. Sica, K. Zachariae, I. Colditz, M. Baggiolini, F. Q. Cunha, B. B. Lorenzetti, S. H. Ferreira, T. J. Standiford, S. L. Kunkel, R. M. Strieter, S. W. Chensue, J. Westwick, K. Kasahara, R. A. Ribeiro, L. H. Faccioli, G. E. P. Souza, C. A. Flores, K. Kasahara, D. G. Quinn, A. Haslberger, C. Foster, M. Ceska, N. Ryder, E. Kugler, I. Lindley, J. N. W. N. Barker, M. L. Jones, R. S. Mitra, C. Swenson, K. Johnson, J. C. Fantone, V. M. Dixit, B. J. Nickoloff, C. Lam, L. Klein, A. Tuschil, J. Y. Shyy, Y. S. Li, D. W. Massop, J. F. Cornhill, P. E. Kolattukudy, R. Pleass, Z. Brown, L. Fairbanks, R. Thomas   +129 more
openaire   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Analysing research trends: A descriptive study of abstracts submitted to the African Conference on Emergency Medicine 2024. [PDF]

Afr J Emerg Med
Holliman R, Hodkinson P, Cox M.
europepmc   +1 more source

Fibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke: A Multicenter Prospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai, Yang Qu, Reziya Abuduxukuer, Kejia Zhang, Peng Zhang, Xin Tang, Huaimei Zhang, Lijuan Wang, Lichong Yang, Shuangxu Tan, Zhimei Yuan, Ce Han, Lili He, Yuping Zheng, Fenglan Zhao, Lijie Guo, Ligang Jiang, Jinfeng Li, Yongfei Jiang, Xuexia Zou, Dan Xu, Han Xu, Xiaojia Wang, Yingbin Qi, Xuefeng Hu, Yu Zhang, Zhen‐Ni Guo, Hang Jin, on behalf of the Biomarkers of Brain Injury Investigator Study Group   +28 more
wiley   +1 more source

Abstracts

Journal der Schreibberatung, 2018
openaire   +2 more sources

Fluid and Neuroimaging Biomarkers in Microgliopathy Colony‐Stimulating Factor‐1 Receptor‐Related Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela, Madison Reeves, Karen Jansen‐West, Judith Dunmore, Yuping Song, Audrey Strongosky, Sunil Gandhi, Gilana Pikover, Matt Blurton‐Jones, Robert C. Spitale, Erik H. Middlebrooks, Leonard Petrucelli, Mercedes Prudencio, Zbigniew K. Wszolek   +13 more
wiley   +1 more source

Alternate and Emerging Anticoagulation Strategies for Extracorporeal Membrane Oxygenation: A Scoping Review. [PDF]

J Clin Med
Kumar A, Carlo N, Nimmagadda R, Shaikh JD, Khatri S, Varghese V.   +5 more
europepmc   +1 more source

Abstracts [PDF]

Journal of Nematology, 2016
FRANCESCA L. STUBBINS, PAULA AGUDELO, FRANCIS P. F. REAY-JONES, JEREMY K. GREENE   +3 more
openaire   +2 more sources

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source